Related Experiment Video
Updated: Jan 9, 2026

Isolation and Identification of Extravascular Immune Cells of the Heart
Published on: August 23, 2018
Coxsackievirus B3 regulates macrophage polarization through ANXA3 to promote the development of myocarditis
Yanfei Chen1, Xingzhu Liu2, Lijuan Meng3
1Department of Cardiology, Kunming Children's Hospital, Kunming, Yunnan 650034, China.
Background:
Viral myocarditis (VMC) is a common inflammatory disease in children that is caused mainly by Coxsackievirus B3 (CVB3) infection. M1 macrophage polarization is a key pathological event in the progression of CVB3-induced myocarditis, and annexin 3 (ANXA3) plays an important role in the process of macrophage activation. Therefore, this study aimed to investigate the function of ANXA3 in CVB3-induced myocarditis and macrophage polarization.
Methods:
CVB3-challenged mice were used to establish a CVB3-induced myocarditis model, and the polarization of RAW264.7 cells was induced by CVB3 infection. The expression of genes and proteins was detected by RT-qPCR, western blotting, immunohistochemistry, immunofluorescence, and ELISA. The pathological lesions in the cardiac tissue were detected by HE staining. Serum levels of myocardial injury markers were detected using kits.
Results:
We found that ANXA3 expression was increased in VMC. ANXA3 knockdown hindered the progression of CVB3-induced VMC, as manifested by increased body weight, reduced inflammatory cell infiltration in the heart, and decreased serum levels of myocardial injury markers (LDH, CK, CK-MB and cTnI). ANXA3 knockdown also inhibited the M1 polarization of CVB3-infected mouse heart tissue macrophages and RAW264.7 cells in vitro and reduced the levels of the inflammatory cytokines IL-1β, IL-6, and TNF-α. In addition, CVB3 infection promoted the expression of TLR4, MyD88, and p-IκB-α in mouse heart tissues and RAW264.7 cells and the nuclear transfer of NF-κB p65 and inhibited the expression of IκB-α. Mechanistic studies revealed that CVB3 increased ANXA3 expression by activating the TLR4/MyD88 pathway, thereby promoting NF-κB p65 nuclear translocation and the subsequent M1 polarization of macrophages, eventually leading to the development of CVB3-induced myocarditis.
Conclusion:
Our study elucidated the role of ANXA3 in promoting CVB3-induced myocarditis, providing a potential intervention target for the treatment of VMC.
Insights
Annexin 3 (ANXA3) promotes Coxsackievirus B3 (CVB3)-induced viral myocarditis (VMC) by enhancing M1 macrophage polarization. Reducing ANXA3 expression offers a potential therapeutic strategy for VMC treatment.
Area of Science:
- Immunology
- Virology
- Cardiology
Background:
- Viral myocarditis (VMC) is a pediatric inflammatory heart condition primarily caused by Coxsackievirus B3 (CVB3).
- M1 macrophage polarization is a critical factor in CVB3-induced myocarditis pathogenesis.
- Annexin 3 (ANXA3) is implicated in macrophage activation processes.
Purpose of the Study:
- To investigate the role of ANXA3 in CVB3-induced myocarditis.
- To explore the function of ANXA3 in macrophage polarization during CVB3 infection.
Main Methods:
- Established a CVB3-induced myocarditis mouse model and infected RAW264.7 cells.
- Quantified gene and protein expression using RT-qPCR, western blotting, immunohistochemistry, and ELISA.
- Assessed cardiac pathology via HE staining and measured myocardial injury markers.
Main Results:
- ANXA3 expression was elevated in VMC.
- ANXA3 knockdown attenuated VMC progression, reduced cardiac inflammation, and decreased injury markers.
- ANXA3 knockdown inhibited M1 macrophage polarization and pro-inflammatory cytokine release (IL-1β, IL-6, TNF-α).
- CVB3 infection activated the TLR4/MyD88/NF-κB pathway, increasing ANXA3 expression and promoting M1 polarization.
Conclusions:
- ANXA3 plays a crucial role in promoting CVB3-induced myocarditis.
- Targeting ANXA3 presents a potential therapeutic avenue for VMC.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Endocarditis III: Medical Management
Myocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests

